Cardiovascular safety of sulphonylurea: comment on the study by Monami et al.

E-ISSN： 1463-1326|16|7|667-669

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.16, Iss.7, 2014-07, pp. : 667-669

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is the Homeostatic Model Assessment of Insulin Resistance a Poor Predictor of Cardiovascular Disease in Rheumatoid Arthritis? Comment on the Article by Giles et al

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2548-2550

John Wiley & Sons Inc

Access to resources Recommend Favorite

Half‐Life and Safety of Canakinumab in Pediatric Patients: Comment on the Article by Ilowite et al

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 3, 2015-03 ,pp. : 857-858

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to the comment by Bellomo et al.

By Maccariello Elizabeth Soares Márcio Rocha Eduardo

Intensive Care Medicine, Vol. 33, Iss. 10, 2007-10 ,pp. : 1851-1852

Springer Publishing Company

Access to resources Recommend Favorite

Reply to the comment by Skrobik et al.

By Rooij Sophia Jonge Evert

Intensive Care Medicine, Vol. 30, Iss. 7, 2004-07 ,pp. : 1500-1500

Springer Publishing Company

Access to resources Recommend Favorite

Response to Wiwanitkit et al. comment on the report: ‘A randomised trial investigating the safety and efficacy of influenza vaccination in patients with ANCA‐associated vasculitis’

NEPHROLOGY, Vol. 20, Iss. 8, 2015-08 ,pp. : 584-584

John Wiley & Sons Inc

Access to resources Recommend Favorite